Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer

Wolff, A.; Lazar, A.; Bondarenko, I.; Garin, A.; Brincat, S.; Chow, L.; Sun, Y.; Neskovic-Konstanovic, Z.; Guimaraes, R.; Fumoleau, P.; Chan, Arlene; Hachemi, S.; Strahs, A.; Cincotta, M.; Berkenblit, A.; Krygowski, M.; Kang, L.L.; Moore, L.; Hayes, D.

Access Status

Fulltext not available

Authors

Wolff, A.

Lazar, A.

Bondarenko, I.

Garin, A.

Brincat, S.

Chow, L.

Sun, Y.

Neskovic-Konstanovic, Z.

Guimaraes, R.

Fumoleau, P.

Chan, Arlene

Hachemi, S.

Strahs, A.

Cincotta, M.

Berkenblit, A.

Krygowski, M.

Kang, L.L.

Moore, L.

Hayes, D.

Date

2013

Type

Journal Article

Metadata

Show full item record

Citation

Wolff, A. and Lazar, A. and Bondarenko, I. and Garin, A. and Brincat, S. and Chow, L. and Sun, Y. et al. 2013. Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer. Journal of Clinical Oncology. 31 (2): pp. 195-202.

Source Title

Journal of Clinical Oncology